SVS Stock Overview
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.13|
|52 Week High||CA$0.55|
|52 Week Low||CA$0.08|
|1 Month Change||-27.78%|
|3 Month Change||-48.00%|
|1 Year Change||44.44%|
|3 Year Change||-38.10%|
|5 Year Change||-51.85%|
|Change since IPO||-62.86%|
Recent News & Updates
|SVS||CA Personal Products||CA Market|
Return vs Industry: SVS exceeded the Canadian Personal Products industry which returned -6.9% over the past year.
Return vs Market: SVS exceeded the Canadian Market which returned 22.1% over the past year.
|SVS Average Weekly Movement||15.2%|
|Personal Products Industry Average Movement||12.7%|
|Market Average Movement||9.4%|
|10% most volatile stocks in CA Market||17.1%|
|10% least volatile stocks in CA Market||3.5%|
Stable Share Price: SVS is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: SVS's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. Its algal-based production systems are used to produce organic omega nutraceuticals and bio-pharmaceutical active ingredients/therapies. The company develops algae strains for the food enhancement and nutraceutical markets; and producing therapeutic proteins.
Solarvest BioEnergy Fundamentals Summary
|SVS fundamental statistics|
Is SVS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SVS income statement (TTM)|
|Cost of Revenue||CA$42.73k|
Last Reported Earnings
Jul 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.063|
|Net Profit Margin||-42,282.82%|
How did SVS perform over the long term?See historical performance and comparison
Is Solarvest BioEnergy undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Solarvest BioEnergy is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Solarvest BioEnergy has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is Solarvest BioEnergy forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Solarvest BioEnergy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Solarvest BioEnergy performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SVS is currently unprofitable.
Growing Profit Margin: SVS is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SVS is unprofitable, and losses have increased over the past 5 years at a rate of 19.4% per year.
Accelerating Growth: Unable to compare SVS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SVS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (50.2%).
Return on Equity
High ROE: SVS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is Solarvest BioEnergy's financial position?
Financial Position Analysis
Short Term Liabilities: SVS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: SVS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: SVS has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: SVS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SVS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SVS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.2% each year
What is Solarvest BioEnergy current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SVS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SVS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SVS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SVS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SVS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gerri Greenham (70 yo)
Mr. Gerri J. Greenham is a Co-Founder of Phycobiologics Inc. and serves as its President. Mr. Greenham has been the Chief Executive Officer and President of Solarvest BioEnergy Inc. since May 4, 2009. He i...
Experienced Management: SVS's management team is seasoned and experienced (7.3 years average tenure).
Experienced Board: SVS's board of directors are seasoned and experienced ( 12.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.8%.
Solarvest BioEnergy Inc.'s employee growth, exchange listings and data sources
- Name: Solarvest BioEnergy Inc.
- Ticker: SVS
- Exchange: TSXV
- Founded: 2005
- Industry: Personal Products
- Sector: Household
- Market Cap: CA$7.194m
- Shares outstanding: 55.34m
- Website: https://www.solarvest.ca
- Solarvest BioEnergy Inc.
- 439 Helmcken Street
- British Columbia
- V6B 2E6
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/28 23:24|
|End of Day Share Price||2021/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.